Psychiatric Quarterly, Vol. 76, No. 3, Fall 2005 ( 2005) DOI: 10.1007/s11126-005-2978-1 Special Section Addressing Discrepancies Between the Child Psychopharmacology Literature and Prescribing Practices INTRODUCTION Raul R. Silva, M.D. Guest Editor This special section is dedicated to select themes in child and adoles- cent psychiatry. Research efforts in child psychiatric populations have a tendency to lag behind that of their adult counterparts. This has left many physicians who prescribe to children in the lurch. Clinically, child psychiatrist make many decisions that are not always empirically val- idated by the literature. Furthermore, when it comes to prescribing medications to this age group, much of what is done in the community is not Food and Drug Administration (FDA) approved. The recent furor regarding a child’s potential to develop suicidal ideations and/or behaviors as a consequence of taking selective sero- tonin reuptake inhibitors (SSRI’s) highlights the dilemma faced by those who prescribe psychotropic medications to children. For decades there had not been a double blind placebo controlled trial that demon- strated meaningful differences between the antidepressants and placebo treatment in depressed children. Nevertheless, over the last ten years the antidepressants were the second most frequently pre- scribed group of psychiatric medications for
Psychiatric Quarterly – Springer Journals
Published: Jan 1, 2005
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera